Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Wins Clairol Bid Without Swapping OTCs

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble appears committed to strengthening its OTC drug portfolio in the wake of the firm's successful bid for the Clairol hair care business.
Advertisement

Related Content

P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January
P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January
P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January
P&G Pharma Asset Exchange For Bristol's Clairol Possible, Analyst Says
P&G Pharma Asset Exchange For Bristol's Clairol Possible, Analyst Says
Crest WhiteStrips
OTC Prilosec For Chronic Use Needs Explicit Labeling, NDAC, GDAC Advise
Prilosec GERD Indication OTC Appropriateness Debated At NDAC Meeting
BMS Streamlining To Focus On Consumer Medicines, Nutritionals

Topics

Advertisement
UsernamePublicRestriction

Register

PS092599

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel